A new statewide research initiative is underway to evaluate an experimental blood test that could change the future of cancer screening.

Steatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early detection of advanced liver disease through screening presents an opportunity ...